Medartis receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Medartis Holding AG (MEDA)
Medartis Holding AG stock price live, this page displays SIX MEDA stock exchange data. View the MEDA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Medartis Holding AG real time stock price chart below.
What Is the Medartis Holding AG Stock Price Today?
The Medartis Holding AG stock price today is 89.10.
What Is the Stock Symbol for Medartis Holding AG?
The stock symbol for Medartis Holding AG is "MEDA."
What Stock Exchange Does Medartis Holding AG Trade On?
Medartis Holding AG is listed and trades on the Switzerland stock exchange.
Is Medartis Holding AG a Good Stock to Buy?
Determining whether Medartis Holding AG, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MEDA quote. (ISIN: CH0386200239)
What Is the Medartis Holding AG Stock Price Today?
The Medartis Holding AG stock price today is 89.10.
What Is the Stock Symbol for Medartis Holding AG?
The stock symbol for Medartis Holding AG is "MEDA."
What Stock Exchange Does Medartis Holding AG Trade On?
Medartis Holding AG is listed and trades on the Switzerland stock exchange.
Is Medartis Holding AG a Good Stock to Buy?
Determining whether Medartis Holding AG, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MEDA quote. (ISIN: CH0386200239)
89.10
-2.90(-3.15%)
Closed·
Fair Value
An estimate of a Medartis's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
88.20
94.00
52 wk Range
70.60
97.50
MEDA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Medartis's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
88.2094.00
52 wk Range
70.6097.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
MEDA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Medartis's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
108.75
Upside
+22.05%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
- Medartis receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Medartis receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Medartis receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Medartis receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 108.75
(+22.05% Upside)
Medartis Holding AG Earnings Call Summary for H1/2026
- Medartis H1 2026 revenue surged 30.7% to CHF 160.8M with 17% organic growth; core EBITDA rose to CHF 28.8M, margin improved to 18%.
- Company raised full-year organic sales guidance to 17%-19% and increased U.S. KeriMedical TOUCH case target to 1,800 from 1,200 units.
- Core net profit turned positive at CHF 7M vs. CHF 400K loss year-ago; gross margin expanded 140 bps to 81.5% on constant-currency basis.
- Free cash flow negative CHF 10M due to CHF 18M H1 CapEx; management expects meaningful improvement in 2027-2028 as investments normalize.
- Shares rose 2.73% to $90.3; growth broad-based across U.S. (27%), EMEA, and Latin America with TOUCH adoption accelerating rapidly.
Last Updated: 18/08/2026, 09:48
Read Full TranscriptEarnings
Latest Release
Aug 18, 2026
EPS / Forecast
0.41 / --
Revenue / Forecast
160.84M / --
Compare MEDA to Peers and Sector
Metrics to compare | MEDA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMEDAPeersSector | |
|---|---|---|---|---|
P/E Ratio | 76.7x | 23.7x | −0.4x | |
PEG Ratio | 0.03 | −0.12 | 0.00 | |
Price/Book | 4.1x | 3.1x | 2.6x | |
Price / LTM Sales | 3.7x | 1.9x | 3.1x | |
Upside (Analyst Target) | 16.8% | 17.8% | 47.7% | |
Fair Value Upside | Unlock | 22.5% | 6.5% | Unlock |
Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company’s medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for upper and lower extremities, mandible, midface, orthognathic under the APTUS and MODUS names, as well as CMX services through web portal, and kerimedical products. The company was incorporated in 1997 and is headquartered in Basel, Switzerland.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Medartis (MEDA) Stock Price Today?
The Medartis stock price today is 89.10 CHF.
What Stock Exchange Does Medartis Trade On?
Medartis is listed and trades on the Switzerland Stock Exchange.
What Is the Stock Symbol for Medartis?
The stock symbol for Medartis is "MEDA."
What Is the Medartis Market Cap?
As of today, Medartis market cap is 1.15B CHF.
What Is Medartis's Earnings Per Share (TTM)?
The Medartis EPS (TTM) is 1.20.
From a Technical Analysis Perspective, Is MEDA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Medartis Stock Split?
Medartis has split 0 times.
How Many Employees Does Medartis Have?
Medartis has 1428 employees.
What is the current trading status of Medartis (MEDA)?
As of Aug 31, 2026, Medartis (MEDA) is trading at a price of 89.10 CHF, with a previous close of 92.00 CHF. The stock has fluctuated within a day range of 88.20 CHF to 94.00 CHF, while its 52-week range spans from 70.60 CHF to 97.50 CHF.
What Is Medartis (MEDA) Price Target According to Analysts?
The average 12-month price target for Medartis is 108.75 CHF, with a high estimate of 130 CHF and a low estimate of 96 CHF. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +22.05% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.